AnGes Inc (AMGXF)
0.3353
0.00 (0.00%)
USD |
OTCM |
May 17, 16:00
AnGes Cash and Short Term Investments (Quarterly): 13.98M for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 13.98M |
December 31, 2023 | 29.50M |
September 30, 2023 | 39.88M |
June 30, 2023 | 53.64M |
March 31, 2023 | 71.26M |
December 31, 2022 | 84.16M |
September 30, 2022 | 69.58M |
June 30, 2022 | 96.72M |
March 31, 2022 | 126.27M |
December 31, 2021 | 155.55M |
September 30, 2021 | 188.85M |
June 30, 2021 | 215.47M |
March 31, 2021 | 128.33M |
December 31, 2020 | 111.86M |
September 30, 2020 | 116.55M |
June 30, 2020 | 125.96M |
March 31, 2020 | 86.22M |
December 31, 2019 | 92.20M |
September 30, 2019 | 99.79M |
June 30, 2019 | 104.65M |
March 31, 2019 | 85.60M |
December 31, 2018 | 52.42M |
September 30, 2018 | 30.72M |
June 30, 2018 | 22.37M |
March 31, 2018 | 13.70M |
Date | Value |
---|---|
December 31, 2017 | 10.18M |
September 30, 2017 | 11.73M |
June 30, 2017 | 16.39M |
March 31, 2017 | 7.969M |
December 31, 2016 | 8.560M |
September 30, 2016 | 16.69M |
June 30, 2016 | 23.47M |
March 31, 2016 | 7.669M |
December 31, 2015 | 17.22M |
September 30, 2015 | 28.18M |
June 30, 2015 | 38.37M |
March 31, 2015 | 43.17M |
December 31, 2014 | 50.37M |
September 30, 2014 | 65.22M |
June 30, 2014 | 18.82M |
March 31, 2014 | 18.35M |
December 31, 2013 | 21.87M |
September 30, 2013 | 28.87M |
June 30, 2013 | 23.40M |
March 31, 2013 | 14.94M |
December 31, 2012 | 4.126M |
September 30, 2012 | 8.804M |
June 30, 2012 | 12.08M |
March 31, 2012 | 14.39M |
December 31, 2011 | 20.28M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
13.98M
Minimum
Mar 2024
215.47M
Maximum
Jun 2021
100.52M
Average
98.25M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
Takeda Pharmaceutical Co Ltd | 3.124B |
Nxera Pharma Co Ltd | 307.32M |
PeptiDream Inc | 180.64M |
Healios KK | 55.40M |
SanBio Co Ltd | 30.23M |